XML 20 R6.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Series B Preferred Stock
Cumulative Effect, Period Of Adoption, Adjustment
Cumulative Effect, Period Of Adoption, Adjusted Balance
Preferred Stock
Preferred Stock
Cumulative Effect, Period Of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period Of Adoption, Adjusted Balance
Treasury Stock
Treasury Stock
Cumulative Effect, Period Of Adoption, Adjusted Balance
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period Of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period Of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Series B Preferred Stock
Retained Earnings
Cumulative Effect, Period Of Adoption, Adjustment
Retained Earnings
Cumulative Effect, Period Of Adoption, Adjusted Balance
Beginning Balance, issued (in shares) at Dec. 31, 2019         4,000,000 4,000,000 453,599,926 453,599,926                    
Beginning Balance (in shares) at Dec. 31, 2019             421,093,364 421,093,364 (32,506,562) (32,506,562)                
Beginning Balance at Dec. 31, 2019 $ 3,311,836   $ (952,639) $ 2,359,197 $ 400,000 $ 400,000 $ 90,720 $ 90,720 $ (324,659) $ (324,659) $ 1,307,630 $ 1,307,630 $ (12,367) $ (12,367) $ 1,850,512   $ (952,639) $ 897,873
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net income 362,173                           362,173      
Other comprehensive loss, net of tax (30,907)                       (30,907)          
Total comprehensive income 331,266                                  
Dividends, Cash [Abstract]                                    
Common Stock (12,595)                           (12,595)      
Preferred Stock   $ (3,464)                           $ (3,464)    
Dividend equivalent units related to employee stock-based compensation plans $ 0                   265       (265)      
Issuance of common shares (in shares) 2,837,562           2,837,562                      
Issuance of common shares $ 2,872           $ 568       2,304              
Stock-based compensation expense $ 13,610                   13,610       0      
Common stock repurchased (in shares) (47,736,847)           (47,736,847)   (47,736,847)                  
Common stock repurchased $ (558,167)               $ (461,244)   (96,923)              
Shares repurchased related to employee stock-based compensation plans (in shares) (1,105,119)           (1,105,119)   (1,105,119)                  
Shares repurchased related to employee stock-based compensation plans $ (12,136)               $ (12,136)                  
Ending Balance, issued (in shares) at Mar. 31, 2020         4,000,000   456,437,488                      
Ending Balance (in shares) at Mar. 31, 2020             375,088,960   (81,348,528)                  
Ending Balance at Mar. 31, 2020 2,120,583       $ 400,000   $ 91,288   $ (798,039)   1,226,886   (43,274)   1,243,722      
Beginning Balance, issued (in shares) at Dec. 31, 2020         2,510,696   456,729,251                      
Beginning Balance (in shares) at Dec. 31, 2020             375,287,999   (81,441,252)                  
Beginning Balance at Dec. 31, 2020 2,562,835       $ 251,070   $ 91,346   $ (798,993)   1,331,247   (34,200)   1,722,365      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net income 641,207                           641,207      
Other comprehensive loss, net of tax 10,123                       10,123          
Total comprehensive income 651,330                                  
Dividends, Cash [Abstract]                                    
Common Stock (10,906)                           (10,906)      
Preferred Stock   $ (1,201)                           $ (1,201)    
Dividend equivalent units related to employee stock-based compensation plans $ (16)                   463       (479)      
Issuance of common shares (in shares) 2,826,387           2,826,387                      
Issuance of common shares $ 2,061           $ 565       1,496              
Stock-based compensation expense 11,124                   11,124              
Common stock repurchased and cancelled (in shares)             (28,502,460)                      
Common stock repurchased and cancelled $ (471,810)           $ (5,700)       (466,110)              
Common stock repurchased (in shares) (48,702,830)           (20,200,370)   (20,200,370)                  
Common stock repurchased $ (120,640)               $ (295,324)   174,684              
Shares repurchased related to employee stock-based compensation plans (in shares) (1,059,980)           (1,059,980)   (1,059,980)                  
Shares repurchased related to employee stock-based compensation plans $ (14,313)               $ (14,313)                  
Ending Balance, issued (in shares) at Mar. 31, 2021         2,510,696   431,053,178                      
Ending Balance (in shares) at Mar. 31, 2021             328,351,576   (102,701,602)                  
Ending Balance at Mar. 31, 2021 $ 2,608,464       $ 251,070   $ 86,211   $ (1,108,630)   $ 1,052,904   $ (24,077)   $ 2,350,986